Department of Endocrinology and Diabetology of Ludwik Rydygier, Collegium Medicum in Bydgoszcz, University of Nicolaus Copernicus in Toruń, ul. M. Skłodowskiej-Curie 9, Bydgoszcz, Poland.
Endokrynol Pol. 2012;63(1):14-7.
Chronic lymphocytic thyroiditis, also known as Hashimoto's thyroiditis, is the most frequent type of thyroiditis. An average of 2% of the population have the disease. It occurs in all age groups, also in children. The main cause of the disease are autoimmune disorders, which results in incresed risk of suffering from type 1 diabetes. Fourthermore, during the course of Hashimoto's thyroiditis, hypothyroidism may cause carbohydrate metabolism disorders. Aim of our study was estimate disturbances of glycaemia in patients with recognized Hashimoto's thyroiditis, hospitalized in Endokrinology and Diabetology Depatment of Collegium Medicum University of Nicolaus Copernicus in Bydgoszcz in years 2001-2010.
We examined 54 patients with the diagnosis of Hashimoto thyroiditis based on clinical picture and examination(autoantibodies anti-TPO and anti-Tg).
In the tested group with Hashimoto's thyroiditis, diabetes has been confirmed in 27.8% of the patients; impaired fasting glycaemia (IFG) or impaired glucose tolerance (IGT) occurred in 16.6%, whereas a normoglycaemia has been confirmed in 55.6% of the pacients. An average age of the patients with Hashimoto's thyroiditis and diabetes at the same time, was 53 years. The patients in which we confirmed the impaired fasting glycaemia or impaired glucose tolerance were on average 49.9 years old. An average age of the patients without any carbohydrate methabolism disorders was on average 43.1 years.
Carbohydrate metabolism disorders in the form of type 1 diabetes connected with an autoimmune process, as well as type 2 diabetes connected with the increase of the insulin resistance, occured in average of half of the patients with Hashimoto's thyroiditis.
慢性淋巴细胞性甲状腺炎,也称桥本甲状腺炎,是最常见的甲状腺炎类型。人群中平均有 2%的人患有这种疾病。它可发生于所有年龄段,也可发生于儿童。该病的主要病因是自身免疫紊乱,由此增加了患 1 型糖尿病的风险。此外,在桥本甲状腺炎的过程中,甲状腺功能减退可能导致碳水化合物代谢紊乱。我们的研究目的是评估在 2001 年至 2010 年期间在比得哥什尼科罗兹大学医学院内分泌和糖尿病科住院的已确诊桥本甲状腺炎患者的血糖紊乱情况。
我们根据临床症状和检查(抗甲状腺过氧化物酶抗体和抗甲状腺球蛋白抗体)检查了 54 例桥本甲状腺炎患者。
在桥本甲状腺炎患者中,有 27.8%的患者确诊为糖尿病;16.6%的患者空腹血糖受损(IFG)或葡萄糖耐量受损(IGT),55.6%的患者血糖正常。同时患有桥本甲状腺炎和糖尿病的患者平均年龄为 53 岁,空腹血糖受损或葡萄糖耐量受损的患者平均年龄为 49.9 岁,无任何碳水化合物代谢紊乱的患者平均年龄为 43.1 岁。
与自身免疫过程相关的 1 型糖尿病和与胰岛素抵抗增加相关的 2 型糖尿病等碳水化合物代谢紊乱,在平均一半的桥本甲状腺炎患者中发生。